Physics and AI Driven Precision Engineering of Novel Drugs
Health + Time : Priceless
We Engineer New Treatments Atom by Atom
To help you live healthier, longer
Your browser does not support the video tag.
For a range of major human diseases, we’re developing treatments that cannot be found through any other method
For a range of major human diseases, we’re developing treatments that cannot be found through any other method
Your browser does not support the video tag.
First-in-Class Drug Candidates
to Change the Standard of Care for Every Disease We Address
PREVENTING HEART ATTACKS & STROKES WITH LOWER BLEEDING RISK
to help
185.7M
patients
2 Candidates
VE-1902, VE-2851
Stage: Clinical
PREVENTING & TREATING DIABETIC VISION LOSS WITHOUT EYE INJECTIONS
to help
179M
patients
2 Candidates
VE-4840, VE-3539
Stage: IND-Prep
PROVIDING CHEMO AGENTS FOR MULTIDRUG-RESISTANT CANCERS
to help
10M
patients
2 Candidates
VE-4054, VE-4932
Stage: Preclinical
PREVENTING AGGRESSIVE SOLID-TUMOR CANCER METASTASIS
to help
9M
patients
2 Candidates
VE-2843, VE-1787
Stage: Optimization
RESTORING IMMUNE RESPONE TO CD73 POSITIVE CANCERS
to help
6.5M
patients
2 Candidates
VE-3771, VE-5953
Stage: Preclinical
+
Many More…
Previous
Next
More about our pipeline
Recent News
First-in-Class Drug Candidates
to Change the Standard of Care for Every Disease We Address
PREVENTING HEART ATTACKS & STROKES WITH LOWER BLEEDING RISK
to help
185.7M
patients
2 Candidates
VE-1902, VE-2851
Stage: Clinical
PREVENTING & TREATING DIABETIC VISION LOSS WITHOUT EYE INJECTIONS
to help
179M
patients
2 Candidates
VE-4840, VE-3539
Stage: IND-Prep
PROVIDING CHEMO AGENTS FOR MULTIDRUG-RESISTANT CANCERS
to help
10M
patients
2 Candidates
VE-4054, VE-4932
Stage: Preclinical
PREVENTING AGGRESSIVE SOLID-TUMOR CANCER METASTASIS
to help
9M
patients
2 Candidates
VE-2843, VE-1787
Stage: Optimization
RESTORING IMMUNE RESPONE TO CD73 POSITIVE CANCERS
to help
6.5M
patients
2 Candidates
VE-3771, VE-5953
Stage: Preclinical
+
Many More…
Previous
Next
More about our pipeline
Recent News
Our stories
Verseon CEO Adityo Prakash Discusses AI in Healthcare with Health Connective
Current drug-discovery AI lacks actionable data. But Verseon combined its breakthroughs in quantum physics with its proprietary explainable AI to find drugs poised to change the standard of care for major human diseases.
APRIL 9, 2024
Will AI Impact Healthcare Costs?
Verseon CEO Adityo Prakash tells ABC News, “AI will make healthcare delivery more efficient. But a major factor that determines cost... is human greed. Unfortunately, AI can’t help us there.”
APRIL 8, 2024
The Future of Pharma Is Deep Quantum Modeling
Verseon CEO Adityo Prakash discusses systematically creating era-defining treatments with California Business Journal
March 1, 2024
Preeminent Cancer Biologist Edison Liu Joins Verseon Scientific Advisory Board
Award-winning international cancer and genomics expert to advise Verseon on program development
February 7, 2024
The Future of AI in the Pharma Industry
Verseon CEO Adityo Prakash discusses the present and future of AI in the pharma industry with NBC News
February 2, 2024
US Patent Issued for Verseon PROAC
Drug candidate promises to greatly improve standard of care for several hundred million cardiovascular patients
January 24, 2024
Verseon Charts the Unknown with Physics and AI
What the world needs are fundamentally novel treatments with new therapeutic profiles
December 20, 2023
Verseon Pioneers Real-time Explainable AI
Revolutionary approach gives robust insights in real time into how AI models reach decisions
December 7, 2023
Verseon CEO Adityo Prakash Discusses AI in Healthcare with Health Connective
Current drug-discovery AI lacks actionable data. But Verseon combined its breakthroughs in quantum physics with its proprietary explainable AI to find drugs poised to change the standard of care for major human diseases.
APRIL 9, 2024
Will AI Impact Healthcare Costs?
Verseon CEO Adityo Prakash tells ABC News, “AI will make healthcare delivery more efficient. But a major factor that determines cost... is human greed. Unfortunately, AI can’t help us there.”
APRIL 8, 2024
The Future of Pharma Is Deep Quantum Modeling
Verseon CEO Adityo Prakash discusses systematically creating era-defining treatments with California Business Journal
March 1, 2024
Preeminent Cancer Biologist Edison Liu Joins Verseon Scientific Advisory Board
Award-winning international cancer and genomics expert to advise Verseon on program development
February 7, 2024
The Future of AI in the Pharma Industry
Verseon CEO Adityo Prakash discusses the present and future of AI in the pharma industry with NBC News
February 2, 2024
US Patent Issued for Verseon PROAC
Drug candidate promises to greatly improve standard of care for several hundred million cardiovascular patients
January 24, 2024
Verseon Charts the Unknown with Physics and AI
What the world needs are fundamentally novel treatments with new therapeutic profiles
December 20, 2023
Verseon Pioneers Real-time Explainable AI
Revolutionary approach gives robust insights in real time into how AI models reach decisions
December 7, 2023
More News
Our stories
Verseon CEO Adityo Prakash Discusses AI in Healthcare with Health Connective
Current drug-discovery AI lacks actionable data. But Verseon combined its breakthroughs in quantum physics with its proprietary explainable AI to find drugs poised to change the standard of care for major human diseases.
April 9, 2024
Will AI Impact Healthcare Costs?
Verseon CEO Adityo Prakash tells ABC News, "AI will make healthcare delivery more efficient. But a major factor that determines cost... is human greed. Unfortunately, AI can’t help us there."
April 8, 2024
The Future of Pharma Is Deep Quantum Modeling
Verseon CEO Adityo Prakash discusses systematically creating era-defining treatments with California Business Journal
March 1, 2024
Preeminent Cancer Biologist Edison Liu Joins Verseon Scientific Advisory Board
Award-winning international cancer and genomics expert to advise Verseon on program development
February 7, 2024
More News
Changing everything the world can expect from 21st Century Medicine
Continue to
Company
Your browser does not support the video tag.